The Chicago Entrepreneur

Novo Nordisk, Eli Lilly singled out by Biden, Sanders over drug prices

Shares of Novo Nordisk and Eli Lilly & Co. dropped early Tuesday after President Joe Biden and Sen. Bernie Sanders took aim at obesity and diabetes drug prices in a USA Today opinion piece.

Previous post U.S. stocks could rise another 10% by the end of 2024 after a strong first half, history shows
Next post Why Adobe and Uber are newly named top stock picks at Deutsche Bank